The short answer
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It combines a four-residue fragment of ACTH with a Pro-Gly-Pro extension that confers stability and removes the parent hormone's adrenal-stimulating activity.
Key facts
- Sequence
- H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
- Single-letter
- MEHFPGP
- Length
- 7 residues (heptapeptide)
- Molecular weight
- 813.9 Da
- Molecular formula
- C37H51N9O10S
- CAS number
- 80714-61-0
- PubChem CID
- 9811102
- Origin
- Institute of Molecular Genetics, RAS
- Western approval
- None (not MHRA, EMA or FDA approved)
Where it comes from
Semax was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its design starts from adrenocorticotropic hormone, a 39-residue pituitary hormone, and takes a short N-terminal-region fragment of it. The peptide has been registered as a prescription medicine in the Russian Federation since the 1990s, and is not approved by any Western regulator.
The Pro-Gly-Pro extension does two jobs
This is the design feature that defines the molecule. Appending Pro-Gly-Pro to the ACTH fragment sharply increases resistance to enzymatic degradation, because proline-rich sequences are poor substrates for most peptidases. It also removes the steroidogenic activity of the parent hormone. Semax does not stimulate adrenal steroid production, which is what separates it pharmacologically from ACTH itself.
Research material referenced
Semax 10mg, third-party HPLC tested
Reported mechanism
The published work centres on neurotrophins. Semax has been reported to upregulate expression of brain-derived neurotrophic factor and nerve growth factor, with downstream signalling through their TrkB and TrkA receptors. Additional reported activity includes modulation of dopaminergic and serotonergic transmission and interaction with the endogenous opioid system. Most of this is rodent work.
The evidence base, described accurately
PubMed indexes roughly 231 records. The mechanistic literature includes work in Brain Research, BMC Genomics and the Journal of Molecular Neuroscience, and is largely conducted in rats. The clinical literature is substantially published in Russian-language journals, principally the Korsakov Journal of Neurology and Psychiatry, and much of it predates current trial-reporting standards. That is a description of where the evidence sits, not a dismissal of it.
Regulatory position
Registration in the Russian Federation is a fact about a decision made by a national regulator. It confers nothing outside that jurisdiction. Semax holds no marketing authorisation from the MHRA, EMA or FDA, cannot be prescribed or dispensed in the UK, and is supplied here for laboratory research only.
Frequently asked questions
Is Semax approved in the UK?
No. It is registered as a prescription medicine in the Russian Federation but holds no MHRA, EMA or FDA authorisation, and is supplied for laboratory research only.
How large is the Semax literature?
Around 231 indexed PubMed records. The mechanistic work is largely rodent; the clinical work is largely Russian-language.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubChemPubChem · Semax (CID 9811102)pubchem.ncbi.nlm.nih.gov
- PubMedSemax regulates BDNF and trkB expression. Brain Res 2006 (PMID 16996037)pubmed.ncbi.nlm.nih.gov
- PubMedSemax and gene expression in rat focal ischaemia. BMC Genomics 2014 (PMID 24661604)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Semax (ACTH Fragment Peptide) articles
- Is Semax Really an ACTH(4-10) Analogue?Semax is universally called an ACTH(4-10) analogue, but shares only residues 4-7. Pro-Gly-Pro replaces Arg-Trp-Gly, and that substitution is the point.
- Semax Structure, Sequence and Physical PropertiesSemax is MEHFPGP, 7 residues, 813.9 Da, C37H51N9O10S. Sequence features, the two prolines, the single methionine, and what each means for handling.
- What Are Glyprolines? The Pro-Gly-Pro Motif ExplainedPro-Gly-Pro is a collagen-derived tripeptide used to stabilise designed peptides. Why proline resists peptidases, and what it contributes to Semax and Selank.
- Semax Mechanism: Neurotrophin ExpressionSemax has been reported to upregulate BDNF and NGF expression with downstream TrkB and TrkA signalling. What the rodent studies measured and what they did not.
- Semax in the Published LiteratureAbout 231 indexed PubMed records. The mechanistic work is rodent, the clinical work largely Russian-language. How to read an unevenly distributed evidence base.